Relationship between IgG1 and IgG4 antibodies to foods and the development of IgE antibodies to inhalant allergens. II. Increased levels of IgG antibodies to foods in children who subsequently develop IgE antibodies to inhalant allergens
Identifieur interne : 000189 ( Istex/Curation ); précédent : 000188; suivant : 000190Relationship between IgG1 and IgG4 antibodies to foods and the development of IgE antibodies to inhalant allergens. II. Increased levels of IgG antibodies to foods in children who subsequently develop IgE antibodies to inhalant allergens
Auteurs : P. G. Calkhoven [Pays-Bas] ; Marja Aalbers [Pays-Bas] ; V. L. Koshte [Pays-Bas] ; P. P. M. Schilte [Pays-Bas] ; J. L. Yntema [Pays-Bas] ; R. W. Griffioen [Pays-Bas] ; J. C. Van Nierop [Pays-Bas] ; A. P. Oranje [Pays-Bas] ; R. C. Aalberse [Pays-Bas]Source :
- Clinical & Experimental Allergy [ 0954-7894 ] ; 1991-01.
Abstract
In the present investigation we have tested the hypothesis that children with a high IgG antibody response to foods have an increased risk of developing IgE antibodies to inhalant allergens. Sera from 106 children with an increased risk of developing IgE‐mediated allergy were analysed. During the follow‐up, in 54 of these children IgE antibodies to inhalant allergens appeared. A positive/negative IgG1 and IgG4 anti‐food score was determined as described previously: sera from age‐clustered unselected children were tested for the levels of IgG1 and IgG4 antibodies to common foods. For each IgG RAST and each age group, the 75‐percentile was chosen as cut‐off value. Each antibody level was thus converted into a positive (higher than the 75‐percentile of the age group) or negative value. The number of positive tests was used as the score. High‐risk children with a high IgG1 anti‐food score more often developed inhalant‐specific IgE antibodies than high‐risk children with low IgG1 titres: 50% of the children with a high IgG1 anti‐food score developed IgE antibodies to grass pollen, whereas only 16% of the children with a low IgG1 anti‐food score acquired IgE anti‐grass pollen. Fifty percent of the children with a high and 14% of the children with a low IgG1 anti‐food score developed IgE antibodies to cat dander. For the prediction of the development of IgE anti‐mite (house dust mite), the IgG4 anti‐food scores appeared less useful than the IgG1 anti‐food scores; 46% of the IgG4 high responders versus 22% of the IgG4 low responders acquired IgE anti‐mite, whereas for IgG1 these precentages were 73 and 19, respectively.
Url:
DOI: 10.1111/j.1365-2222.1991.tb00810.x
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000189
Links to Exploration step
ISTEX:CC420245CEDDB9E18A44A2AFF9327ED4F0022D39Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Relationship between IgG1 and IgG4 antibodies to foods and the development of IgE antibodies to inhalant allergens. II. Increased levels of IgG antibodies to foods in children who subsequently develop IgE antibodies to inhalant allergens</title><author><name sortKey="Calkhoven, P G" sort="Calkhoven, P G" uniqKey="Calkhoven P" first="P. G." last="Calkhoven">P. G. Calkhoven</name><affiliation wicri:level="1"><mods:affiliation>Central Laboratory of The Netherlands Red Cross Blood Transfusion Service and Laboratory for Experimental and Clinical Immunology, University of Amsterdam, The Netherlands</mods:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Central Laboratory of The Netherlands Red Cross Blood Transfusion Service and Laboratory for Experimental and Clinical Immunology, University of Amsterdam</wicri:regionArea></affiliation></author><author><name sortKey="Aalbers, Marja" sort="Aalbers, Marja" uniqKey="Aalbers M" first="Marja" last="Aalbers">Marja Aalbers</name><affiliation wicri:level="1"><mods:affiliation>Central Laboratory of The Netherlands Red Cross Blood Transfusion Service and Laboratory for Experimental and Clinical Immunology, University of Amsterdam, The Netherlands</mods:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Central Laboratory of The Netherlands Red Cross Blood Transfusion Service and Laboratory for Experimental and Clinical Immunology, University of Amsterdam</wicri:regionArea></affiliation></author><author><name sortKey="Koshte, V L" sort="Koshte, V L" uniqKey="Koshte V" first="V. L." last="Koshte">V. L. Koshte</name><affiliation wicri:level="1"><mods:affiliation>Central Laboratory of The Netherlands Red Cross Blood Transfusion Service and Laboratory for Experimental and Clinical Immunology, University of Amsterdam, The Netherlands</mods:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Central Laboratory of The Netherlands Red Cross Blood Transfusion Service and Laboratory for Experimental and Clinical Immunology, University of Amsterdam</wicri:regionArea></affiliation></author><author><name sortKey="Schilte, P P M" sort="Schilte, P P M" uniqKey="Schilte P" first="P. P. M." last="Schilte">P. P. M. Schilte</name><affiliation wicri:level="1"><mods:affiliation>Medical Centre Alkmaar, Alkmaar, The Netherlands</mods:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Medical Centre Alkmaar, Alkmaar</wicri:regionArea></affiliation></author><author><name sortKey="Yntema, J L" sort="Yntema, J L" uniqKey="Yntema J" first="J. L." last="Yntema">J. L. Yntema</name><affiliation wicri:level="1"><mods:affiliation>Medical Centre Alkmaar, Alkmaar, The Netherlands</mods:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Medical Centre Alkmaar, Alkmaar</wicri:regionArea></affiliation></author><author><name sortKey="Griffioen, R W" sort="Griffioen, R W" uniqKey="Griffioen R" first="R. W." last="Griffioen">R. W. Griffioen</name><affiliation wicri:level="1"><mods:affiliation>Emma Children's Hospital, Amsterdam, The Netherlands</mods:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Emma Children's Hospital, Amsterdam</wicri:regionArea></affiliation></author><author><name sortKey="Van Nierop, J C" sort="Van Nierop, J C" uniqKey="Van Nierop J" first="J. C." last="Van Nierop">J. C. Van Nierop</name><affiliation wicri:level="1"><mods:affiliation>Emma Children's Hospital, Amsterdam, The Netherlands</mods:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Emma Children's Hospital, Amsterdam</wicri:regionArea></affiliation></author><author><name sortKey="Oranje, A P" sort="Oranje, A P" uniqKey="Oranje A" first="A. P." last="Oranje">A. P. Oranje</name><affiliation wicri:level="1"><mods:affiliation>University Hospital Rotterdam/Sophia Children's Hospital, Rotterdam, The Netherlands</mods:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>University Hospital Rotterdam/Sophia Children's Hospital, Rotterdam</wicri:regionArea></affiliation></author><author><name sortKey="Aalberse, R C" sort="Aalberse, R C" uniqKey="Aalberse R" first="R. C." last="Aalberse">R. C. Aalberse</name><affiliation wicri:level="1"><mods:affiliation>Central Laboratory of The Netherlands Red Cross Blood Transfusion Service and Laboratory for Experimental and Clinical Immunology, University of Amsterdam, The Netherlands</mods:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Central Laboratory of The Netherlands Red Cross Blood Transfusion Service and Laboratory for Experimental and Clinical Immunology, University of Amsterdam</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:CC420245CEDDB9E18A44A2AFF9327ED4F0022D39</idno><date when="1991" year="1991">1991</date><idno type="doi">10.1111/j.1365-2222.1991.tb00810.x</idno><idno type="url">https://api.istex.fr/document/CC420245CEDDB9E18A44A2AFF9327ED4F0022D39/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000189</idno><idno type="wicri:Area/Istex/Curation">000189</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Relationship between IgG1 and IgG4 antibodies to foods and the development of IgE antibodies to inhalant allergens. II. Increased levels of IgG antibodies to foods in children who subsequently develop IgE antibodies to inhalant allergens</title><author><name sortKey="Calkhoven, P G" sort="Calkhoven, P G" uniqKey="Calkhoven P" first="P. G." last="Calkhoven">P. G. Calkhoven</name><affiliation wicri:level="1"><mods:affiliation>Central Laboratory of The Netherlands Red Cross Blood Transfusion Service and Laboratory for Experimental and Clinical Immunology, University of Amsterdam, The Netherlands</mods:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Central Laboratory of The Netherlands Red Cross Blood Transfusion Service and Laboratory for Experimental and Clinical Immunology, University of Amsterdam</wicri:regionArea></affiliation></author><author><name sortKey="Aalbers, Marja" sort="Aalbers, Marja" uniqKey="Aalbers M" first="Marja" last="Aalbers">Marja Aalbers</name><affiliation wicri:level="1"><mods:affiliation>Central Laboratory of The Netherlands Red Cross Blood Transfusion Service and Laboratory for Experimental and Clinical Immunology, University of Amsterdam, The Netherlands</mods:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Central Laboratory of The Netherlands Red Cross Blood Transfusion Service and Laboratory for Experimental and Clinical Immunology, University of Amsterdam</wicri:regionArea></affiliation></author><author><name sortKey="Koshte, V L" sort="Koshte, V L" uniqKey="Koshte V" first="V. L." last="Koshte">V. L. Koshte</name><affiliation wicri:level="1"><mods:affiliation>Central Laboratory of The Netherlands Red Cross Blood Transfusion Service and Laboratory for Experimental and Clinical Immunology, University of Amsterdam, The Netherlands</mods:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Central Laboratory of The Netherlands Red Cross Blood Transfusion Service and Laboratory for Experimental and Clinical Immunology, University of Amsterdam</wicri:regionArea></affiliation></author><author><name sortKey="Schilte, P P M" sort="Schilte, P P M" uniqKey="Schilte P" first="P. P. M." last="Schilte">P. P. M. Schilte</name><affiliation wicri:level="1"><mods:affiliation>Medical Centre Alkmaar, Alkmaar, The Netherlands</mods:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Medical Centre Alkmaar, Alkmaar</wicri:regionArea></affiliation></author><author><name sortKey="Yntema, J L" sort="Yntema, J L" uniqKey="Yntema J" first="J. L." last="Yntema">J. L. Yntema</name><affiliation wicri:level="1"><mods:affiliation>Medical Centre Alkmaar, Alkmaar, The Netherlands</mods:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Medical Centre Alkmaar, Alkmaar</wicri:regionArea></affiliation></author><author><name sortKey="Griffioen, R W" sort="Griffioen, R W" uniqKey="Griffioen R" first="R. W." last="Griffioen">R. W. Griffioen</name><affiliation wicri:level="1"><mods:affiliation>Emma Children's Hospital, Amsterdam, The Netherlands</mods:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Emma Children's Hospital, Amsterdam</wicri:regionArea></affiliation></author><author><name sortKey="Van Nierop, J C" sort="Van Nierop, J C" uniqKey="Van Nierop J" first="J. C." last="Van Nierop">J. C. Van Nierop</name><affiliation wicri:level="1"><mods:affiliation>Emma Children's Hospital, Amsterdam, The Netherlands</mods:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Emma Children's Hospital, Amsterdam</wicri:regionArea></affiliation></author><author><name sortKey="Oranje, A P" sort="Oranje, A P" uniqKey="Oranje A" first="A. P." last="Oranje">A. P. Oranje</name><affiliation wicri:level="1"><mods:affiliation>University Hospital Rotterdam/Sophia Children's Hospital, Rotterdam, The Netherlands</mods:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>University Hospital Rotterdam/Sophia Children's Hospital, Rotterdam</wicri:regionArea></affiliation></author><author><name sortKey="Aalberse, R C" sort="Aalberse, R C" uniqKey="Aalberse R" first="R. C." last="Aalberse">R. C. Aalberse</name><affiliation wicri:level="1"><mods:affiliation>Central Laboratory of The Netherlands Red Cross Blood Transfusion Service and Laboratory for Experimental and Clinical Immunology, University of Amsterdam, The Netherlands</mods:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Central Laboratory of The Netherlands Red Cross Blood Transfusion Service and Laboratory for Experimental and Clinical Immunology, University of Amsterdam</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Clinical & Experimental Allergy</title><idno type="ISSN">0954-7894</idno><idno type="eISSN">1365-2222</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="1991-01">1991-01</date><biblScope unit="volume">21</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="99">99</biblScope><biblScope unit="page" to="107">107</biblScope></imprint><idno type="ISSN">0954-7894</idno></series><idno type="istex">CC420245CEDDB9E18A44A2AFF9327ED4F0022D39</idno><idno type="DOI">10.1111/j.1365-2222.1991.tb00810.x</idno><idno type="ArticleID">CEA99</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0954-7894</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In the present investigation we have tested the hypothesis that children with a high IgG antibody response to foods have an increased risk of developing IgE antibodies to inhalant allergens. Sera from 106 children with an increased risk of developing IgE‐mediated allergy were analysed. During the follow‐up, in 54 of these children IgE antibodies to inhalant allergens appeared. A positive/negative IgG1 and IgG4 anti‐food score was determined as described previously: sera from age‐clustered unselected children were tested for the levels of IgG1 and IgG4 antibodies to common foods. For each IgG RAST and each age group, the 75‐percentile was chosen as cut‐off value. Each antibody level was thus converted into a positive (higher than the 75‐percentile of the age group) or negative value. The number of positive tests was used as the score. High‐risk children with a high IgG1 anti‐food score more often developed inhalant‐specific IgE antibodies than high‐risk children with low IgG1 titres: 50% of the children with a high IgG1 anti‐food score developed IgE antibodies to grass pollen, whereas only 16% of the children with a low IgG1 anti‐food score acquired IgE anti‐grass pollen. Fifty percent of the children with a high and 14% of the children with a low IgG1 anti‐food score developed IgE antibodies to cat dander. For the prediction of the development of IgE anti‐mite (house dust mite), the IgG4 anti‐food scores appeared less useful than the IgG1 anti‐food scores; 46% of the IgG4 high responders versus 22% of the IgG4 low responders acquired IgE anti‐mite, whereas for IgG1 these precentages were 73 and 19, respectively.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Informatique/explor/ScrumV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000189 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 000189 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Informatique
|area= ScrumV1
|flux= Istex
|étape= Curation
|type= RBID
|clé= ISTEX:CC420245CEDDB9E18A44A2AFF9327ED4F0022D39
|texte= Relationship between IgG1 and IgG4 antibodies to foods and the development of IgE antibodies to inhalant allergens. II. Increased levels of IgG antibodies to foods in children who subsequently develop IgE antibodies to inhalant allergens
}}
| This area was generated with Dilib version V0.6.39. |  |